Identification and validation of TNFRSF4 as a high-profile biomarker for prognosis and immunomodulation in endometrial carcinoma

BACKGROUND: The interaction between tumor microenvironment (TME) and tumors offers various targets in mounting anti-tumor immunotherapies. However, the prognostic biomarkers in endometrial carcinoma (EC) are still limited. Here, we aimed to analyze the TME features and identify novel prognostic biom...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Heng, Feng, Peng-hui, Yu, Shuang-ni, Lu, Zhao-hui, Yu, Qi, Chen, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9107201/
https://www.ncbi.nlm.nih.gov/pubmed/35562682
http://dx.doi.org/10.1186/s12885-022-09654-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9107201/
https://www.ncbi.nlm.nih.gov/pubmed/35562682
http://dx.doi.org/10.1186/s12885-022-09654-6

Ejemplares similares